Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Behrens

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2020
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2Lauren A Henderson, Scott W Canna, Kevin G Friedman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2020
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1Lauren A Henderson, Scott W Canna, Kevin G Friedman, et al.
Blood Advances|December 3, 2025
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH studyAdi Zoref-Lorenz, Carl E Allen, Edward M Behrens, et al.
The Journal of Allergy and Clinical Immunology|September 20, 2024
Serum cytokine panels in pediatric clinical practicePaul M Gallo, Jihwan Kim, Kevin O McNerney, et al.
Science (New York, N.Y.)|July 30, 2021
Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretionRuth Choa, Junichiro Tohyama, Shogo Wada, et al.
Blood Advances|March 1, 2024
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabShanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, et al.
Frontiers in Immunology|March 24, 2025
Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementationLauren A Henderson, Roshini S Abraham, Aisha Ahmed, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
T cell dysregulation and remodeling in pediatric obesity and weight lossCeire A Hay, Samir U Sayed, Diego A Espinoza, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
Differential cytokine architecture in patients treated with CART19 versus CART22Caroline Diorio, Rawan Shraim, Anusha Thadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2020
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2Lauren A Henderson, Scott W Canna, Kevin G Friedman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2020
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1Lauren A Henderson, Scott W Canna, Kevin G Friedman, et al.
Blood Advances|December 3, 2025
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH studyAdi Zoref-Lorenz, Carl E Allen, Edward M Behrens, et al.
The Journal of Allergy and Clinical Immunology|September 20, 2024
Serum cytokine panels in pediatric clinical practicePaul M Gallo, Jihwan Kim, Kevin O McNerney, et al.
Science (New York, N.Y.)|July 30, 2021
Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretionRuth Choa, Junichiro Tohyama, Shogo Wada, et al.
Blood Advances|March 1, 2024
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabShanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, et al.
Frontiers in Immunology|March 24, 2025
Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementationLauren A Henderson, Roshini S Abraham, Aisha Ahmed, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
T cell dysregulation and remodeling in pediatric obesity and weight lossCeire A Hay, Samir U Sayed, Diego A Espinoza, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
Differential cytokine architecture in patients treated with CART19 versus CART22Caroline Diorio, Rawan Shraim, Anusha Thadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.
Pageof 15